Smith & Nephew plc (SNN)
 NYSE: SNN · Real-Time Price · USD
 36.77
 -0.05 (-0.14%)
  At close: Nov 3, 2025, 4:00 PM EST
36.77
 0.00 (0.00%)
  After-hours: Nov 3, 2025, 7:00 PM EST
Smith & Nephew Employees
Smith & Nephew had 18,060 employees as of December 31, 2024. The number of employees decreased by 1,021 or -5.35% compared to the previous year.
Employees 
 18,060
Change (1Y) 
 -1,021
Growth (1Y) 
 -5.35%
Revenue / Employee 
 $329,125
Profits / Employee 
 $27,187
Market Cap 
15.56B
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 18,060 | -1,021 | -5.35% | 
| Dec 31, 2023 | 19,081 | -13 | -0.07% | 
| Dec 31, 2022 | 19,094 | 118 | 0.62% | 
| Dec 31, 2021 | 18,976 | 395 | 2.13% | 
| Dec 31, 2020 | 18,581 | 551 | 3.06% | 
| Dec 31, 2019 | 18,030 | 1,349 | 8.09% | 
| Dec 31, 2018 | 16,681 | 348 | 2.13% | 
| Dec 31, 2017 | 16,333 | 749 | 4.81% | 
| Dec 31, 2016 | 15,584 | 898 | 6.11% | 
| Dec 31, 2015 | 14,686 | 1,218 | 9.04% | 
| Dec 31, 2014 | 13,468 | 2,432 | 22.04% | 
| Dec 31, 2013 | 11,036 | 559 | 5.34% | 
| Dec 31, 2012 | 10,477 | -266 | -2.48% | 
| Dec 31, 2011 | 10,743 | 571 | 5.61% | 
| Dec 31, 2010 | 10,172 | 408 | 4.18% | 
| Dec 31, 2009 | 9,764 | 7 | 0.07% | 
| Dec 31, 2008 | 9,757 | 567 | 6.17% | 
| Dec 31, 2007 | 9,190 | 360 | 4.08% | 
| Dec 31, 2006 | 8,830 | 212 | 2.46% | 
| Dec 31, 2005 | 8,618 | 752 | 9.56% | 
| Dec 31, 2004 | 7,866 | 415 | 5.57% | 
| Feb 16, 2003 | 7,451 | -55 | -0.73% | 
| Dec 31, 2002 | 7,506 | -420 | -5.30% | 
| Dec 31, 2001 | 7,926 | -2,509 | -24.04% | 
| Dec 31, 2000 | 10,435 | -778 | -6.94% | 
| Dec 31, 1999 | 11,213 | - | - | 
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
SNN News
- 7 days ago - Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT - GlobeNewsWire
 - 12 days ago - UFC® and Smith+Nephew announce multi-year extension of partnership - GlobeNewsWire
 - 4 weeks ago - Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention - GlobeNewsWire
 - 4 weeks ago - Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty - GlobeNewsWire
 - 7 weeks ago - Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant - GlobeNewsWire
 - 2 months ago - Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System - GlobeNewsWire
 - 3 months ago - Smith & Nephew: Doing Better And Still Offers Value - Seeking Alpha
 - 3 months ago - Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript - Seeking Alpha